Arcutis Biotherapeutics, Inc. (ARQT): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

127.23M
Year ended 2025-12-31
+32.2%
3-year compound annual growth
+29.0%
5-year compound annual growth
2019-12-31: 1.84M2020-12-31: 35.67M2021-12-31: 49.41M2022-12-31: 55.03M2023-12-31: 69.31M2024-12-31: 120.96M2025-12-31: 127.23M127.23M
2019-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-31127.23M+5.2%2026-02-25, From 2025-01-01
2024-12-31120.96M+74.5%2026-02-25, From 2024-01-01
2023-12-3169.31M+25.9%2026-02-25, From 2023-01-01
2022-12-3155.03M+11.4%2025-02-25, From 2022-01-01
2021-12-3149.41M+38.5%2024-02-27, From 2021-01-01
2020-12-3135.67Mn/m2023-02-28, From 2020-01-01
2019-12-311.84Mn/a2022-02-22, From 2019-01-01